The Asian phase III Stereotactic Body Radiation Therapy in Newly Diagnosed Advanced Staged lung adenocarcinoma (SINDAS) study enrolled 133 patients with oligometastatic EGFR mutated NSCLC, all receiving first generation TKIs therapy. Here, EGFR is linked to non-small cell lung carcinoma.